市场调查报告书
商品编码
1499501
D-胺基酸市场:按类型、产品和最终用途分类 - 全球预测 2024-2030D-Amino Acids Market by Type (Natural, Synthetic), Product (D-Alanine, D-Aspartic Acid, D-Glutamic Acid), End-Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
D-胺基酸市场规模预计2023年为1.9171亿美元,2024年达到2.0032亿美元,预计2030年将达到2.6235亿美元,复合年增长率为4.58%。
D-胺基酸是一种具有多种应用的掌性分子。 D-胺基酸是自然界中广泛存在的L-胺基酸的对映体。 D-胺基酸因其独特的性质而引起人们的关注,并越来越多地应用于製药、生物技术、食品和饲料工业以及研究应用。由于製药工业的不断扩张以及对功效和安全性提高的新药的需求不断增加,对 D-氨基酸的需求不断增加。 D-胺基酸合成和应用创新技术的开拓将推动市场成长。此外,全球健康意识的增强和对饮食习惯的兴趣也推动了食品和饲料行业对 D-氨基酸的需求。 D-胺基酸生产的复杂性和成本不断增加阻碍了市场的成长,特别是在考虑大规模合成时。对映选择性合成新技术的新兴市场开拓预计将导致成本降低和效率提高,从而创造市场成长机会。生物催化的创新和医学新应用的发现,例如胜肽的设计,为市场成长提供了进一步的潜力。与研究机构在神经科学和代谢疾病方面的新应用的合作也为 D-氨基酸市场提供了潜在的成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 1.9171 亿美元 |
预测年份 [2024] | 2亿美元 |
预测年份 [2030] | 26235万美元 |
复合年增长率(%) | 4.58% |
区域洞察
由于对生物技术和药物研究的大量投资,美洲的 D-氨基酸市场仍然强劲。消费者的需求集中在创新配方和胜肽疗法的开发。不断发展的生物技术产业越来越多地购买这些专用胺基酸用于研究和产品开发。慢性病的流行和个人化医疗的推动进一步增加了南美洲对 D-氨基酸的需求。欧盟 (EU) 的製药工业十分完善,对 D-胺基酸的稳定需求主要由新配方的研发驱动。欧盟法规鼓励创新,这体现在成员国 D-胺基酸专利申请数量稳定。对品质和法规合规性的关注正在影响该地区消费者的购买行为。欧盟对生命科学和生物技术研究的投资正在支持 D-氨基酸市场的成长。在中东和非洲,研究机构投资的增加和医疗保健领域的扩张表明 D-氨基酸市场扩张的潜力。由于庞大的製药产业及其在全球供应链中的地位,亚太地区D-胺基酸市场正在不断扩大和成长。亚太地区D-胺基酸新用途的拓展反映了该国研发投资的规模,大量的研究资料和专利就证明了这一点。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在 D-胺基酸市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对 D-胺基酸市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前 D-氨基酸市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[182 Pages Report] The D-Amino Acids Market size was estimated at USD 191.71 million in 2023 and expected to reach USD 200.32 million in 2024, at a CAGR 4.58% to reach USD 262.35 million by 2030.
The D-amino acids are a class of chiral molecules used in various applications. D-amino acids are the enantiomers of naturally prevalent L-amino acids. D-amino acids have gained attention due to their unique properties and increasing use in pharmaceuticals, biotechnology, food and feed industries, and research applications. The pharmaceutical industry is continuously expanding, and there is an increased demand for novel drugs with improved efficacy and safety, creating the need for D-amino acids. The development of innovative technologies for the synthesis and application of D-amino acids fosters market growth. The rise in health awareness and dietary concerns among the global population also propels the demand for D-amino acids in the food and feed sectors. Rising complexity and increasing cost of production of D-amino acids, particularly when considering large-scale synthesis, is hampering the market growth. The rising development of new methods for enantioselective synthesis can lead to cost reduction, and greater efficiency is expected to create opportunities for market growth. Innovations in biocatalysis and the discovery of new applications in medical science, such as in antimicrobial peptide design, provide additional scope for market growth. Collaboration with research institutions for novel applications in neurosciences and metabolic disorders also presents potential opportunities for the growth of the D-amino acids market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 191.71 million |
Estimated Year [2024] | USD 200.32 million |
Forecast Year [2030] | USD 262.35 million |
CAGR (%) | 4.58% |
Regional Insights
The market for D-Amino Acids in the Americas is robust, driven by substantial investments in biotechnology and pharmaceutical research. Consumer needs revolve around innovative drug formulations and the development of peptide-based therapeutics. The growing biotech sector has seen an uptick in purchasing these specialized amino acids for research and product development. The prevalence of chronic diseases and the push for personalized medicine further bolster demand for D-amino acids in South America. The European Union has a well-established pharmaceutical industry with a steady demand for D-amino acids, primarily driven by research and development in novel drug formulations. EU regulations encourage innovation, which is reflected in the steady number of patents being filed relating to D-amino acids within member countries. Emphasis on quality and regulatory compliance influences consumer purchasing behavior in this region. The EU's investment in life sciences and biotechnology research initiatives supports the growth of the D-amino acids market. In the Middle East and Africa, increased investment in research institutions and expansion of healthcare sectors suggest a growing market potential for D-amino acids. Asia-Pacific's D-amino acids market is expansive and growing due to its massive pharmaceutical sector and global supply chain position. The country's significant R&D investment, evidenced by a high volume of research materials and patents, demonstrates the expansion of novel applications for D-amino acids in the Asia-Pacific region.
Market Insights
The market dynamics represent an ever-changing landscape of the D-Amino Acids Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the D-Amino Acids Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the D-Amino Acids Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Grand Pharma Acquired 100% Equity of Hubei Bafeng, Further Expanding the Strategic Plan on High-quality Amino Acid Industry
Grand Pharmaceutical Group Limited announced the strategic acquisition of Hubei Bafeng Pharmaceuticals and Chemicals Share Co., Ltd. for RMB 270 million. This important move follows their acquisition of Cangzhou Huachen BioTech Co., Ltd. in 2021, reinforcing their expansion within the amino acid industry. [Published On: 2023-08-08]
CJ do Brasil Invests ZAR 1.1 Billion and Expands Amino Acid Factory in Piracicaba
CJ do Brasil, a branch of the international powerhouse CJ Bio, celebrated a significant milestone with expanding its Piracicaba facility, roughly 160 kilometers from Sao Paulo. This ZAR 1.1 billion investment anticipates creating 650 new jobs and fortifies the company's unique position in Latin America as the only producer of three vital amino acids for animal nutrition: Lysine, Threonine, and Tryptophan. [Published On: 2023-05-31]
Evonik Strengthens Competitiveness of its Animal Nutrition Business
Evonik announced partitioning its operations into two dedicated segments: amino acids and specialty nutrition, each aligned with specific market demands and conditions. The amino acid sector aims to harness streamlined processes and digital prowess to boost efficiency and maintain cost-competitiveness, while the specialty nutrition segment aims to evolve towards integrated system solutions, emphasizing functional feed additives and digital tools for various livestock categories. [Published On: 2023-04-03]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the D-Amino Acids Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the D-Amino Acids Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amino GmbH, AnaSpec, Inc, Archer-Daniels-Midland Company, Bachem AG, Cargill, Incorporated, Central Drug House (P) Ltd., Creative Enzymes, Evonik Industries AG, IRIS Biotech GmbH, Kyowa Hakkon Kirin Co. Ltd., LG Chem Ltd., Matter and Form Inc., Pepscan, Prinova Group LLC, Sekisui Medical Co. Ltd., Shanghai Brightol International, Shijiazhuang Haitian Amino Acid Co., Ltd., Sichuan Tongsheng Amino acid Co., Ltd., Tokyo Chemical Industry Co., Ltd., Varsal Chemicals, Wacker Chemie AG, Wuhan Amino Acid Bio-Chemical Co., Ltd, Yoneyama Yakuhin Kogyo Co., Ltd., and Zhangjiagang Huachang Pharmaceutical Co. Ltd..
Market Segmentation & Coverage